BindingDB Data by Journal
PMID
Data
Article Title
Citation
Organization
Download Data
Evidence of ternary complex formation in Trypanosoma cruzi trans-sialidase catalysis.
J Biol Chem 289: 423-36 (2014)
Universidade Federal Do Rio De Janeiro
Defining the communication between agonist and coactivator binding in the retinoid X receptor a ligand binding domain.
J Biol Chem 289: 814-26 (2014)
University of Alabama At Birmingham
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor.
J Biol Chem 289: 942-55 (2014)
Genentech
A L-lysine transporter of high stereoselectivity of the amino acid-polyamine-organocation (APC) superfamily: production, functional characterization, and structure modeling.
J Biol Chem 289: 1377-87 (2014)
Max Planck Institute of Biophysics
The molecular chaperone Hsp70 activates protein phosphatase 5 (PP5) by binding the tetratricopeptide repeat (TPR) domain.
J Biol Chem 289: 2908-17 (2014)
University of Michigan
Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
J Biol Chem 289: 4432-43 (2014)
University of Texas Southwestern Medical Center
A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
J Biol Chem 289: 5208-16 (2014)
Universität Duisburg-Essen
The different inhibition mechanisms of OXA-1 and OXA-24 ß-lactamases are determined by the stability of active site carboxylated lysine.
J Biol Chem 289: 6152-64 (2014)
Case Western Reserve University
Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.
J Biol Chem 289: 8839-51 (2014)
Karlsruhe Institute of Technology
Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
J Biol Chem 289: 9304-19 (2014)
Bayer Healthcare
Trimethylation of histone H3 lysine 36 by human methyltransferase PRDM9 protein.
J Biol Chem 289: 12177-88 (2014)
University of Toronto
A novel small-molecule tumor necrosis factor a inhibitor attenuates inflammation in a hepatitis mouse model.
J Biol Chem 289: 12457-66 (2014)
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor ß/d (PPARß/d) in the brain.
J Biol Chem 289: 12748-58 (2014)
Case Western Reserve University School of Medicine
The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity.
J Biol Chem 289: 13042-53 (2014)
Harvard Neurodiscovery Center
Deciphering the binding of caveolin-1 to client protein endothelial nitric-oxide synthase (eNOS): scaffolding subdomain identification, interaction modeling, and biological significance.
J Biol Chem 289: 13273-83 (2014)
St. Paul'S Hospital'S Centre of Heart and Lung Innovation
Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1.
J Biol Chem 289: 13717-25 (2014)
National Institutes of Health
Structural basis of pharmacological chaperoning for human ß-galactosidase.
J Biol Chem 289: 14560-8 (2014)
The University of Tokyo
Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor ß/d (FABP5-PPARß/d) signaling pathway.
J Biol Chem 289: 14941-54 (2014)
Emory University
Functional rescue of Kallmann syndrome-associated prokineticin receptor 2 (PKR2) mutants deficient in trafficking.
J Biol Chem 289: 15518-26 (2014)
Central South University
Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis.
J Biol Chem 289: 15527-35 (2014)
University of Michigan
Oxysterol-binding protein (OSBP)-related protein 4 (ORP4) is essential for cell proliferation and survival.
J Biol Chem 289: 15705-17 (2014)
Dalhousie University
Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor.
J Biol Chem 289: 15987-6005 (2014)
University of Wuerzburg
Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation.
J Biol Chem 289: 16270-7 (2014)
Mcgill University
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.
J Biol Chem 289: 16349-61 (2014)
University of Colorado School of Medicine
In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth.
J Biol Chem 289: 17980-95 (2014)
Harvard School of Public Health
Human UTY(KDM6C) is a male-specific N¿-methyl lysyl demethylase.
J Biol Chem 289: 18302-13 (2014)
University of Oxford
Opioid receptor function is regulated by post-endocytic peptide processing.
J Biol Chem 289: 19613-26 (2014)
Icahn School of Medicine At Mount Sinai
Two amino acid residues confer different binding affinities of Abelson family kinase SRC homology 2 domains for phosphorylated cortactin.
J Biol Chem 289: 19704-13 (2014)
Yale University
ORA1, a zebrafish olfactory receptor ancestral to all mammalian V1R genes, recognizes 4-hydroxyphenylacetic acid, a putative reproductive pheromone.
J Biol Chem 289: 19778-88 (2014)
German Institute of Human Nutrition Potsdam-Rehbruecke
Structure of the Acinetobacter baumannii dithiol oxidase DsbA bound to elongation factor EF-Tu reveals a novel protein interaction site.
J Biol Chem 289: 19869-80 (2014)
University of Queensland
Structure of REV-ERBß ligand-binding domain bound to a porphyrin antagonist.
J Biol Chem 289: 20054-66 (2014)
The Scripps Research Institute
Digoxin derivatives with enhanced selectivity for the a2 isoform of Na,K-ATPase: effects on intraocular pressure in rabbits.
J Biol Chem 289: 21153-62 (2014)
Weizmann Institute of Science
The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability.
J Biol Chem 289: 21651-62 (2014)
Astrazeneca R&D Boston